The reversible MAO inhibitor, brofaromine, inhibits serotonin uptake in vivo

This publication has 15 references indexed in Scilit:

• Ifoxetine, a compound with atypical effects on serotonin uptake
  European Journal of Pharmacology, 1986
• CGP 4718 A, a new potential antidepressant with a dual mode of action
  European Journal of Pharmacology, 1984
• The monoamine oxidase inhibiting properties of CGP 11305 A
  European Journal of Pharmacology, 1983
• Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls
  Psychiatry Research, 1983
• Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A
  European Journal of Clinical Pharmacology, 1983
• Sensitive assay for the tricyclic antidepressant Ro 11-2465 in biological fluids by high-performance liquid chromatography and fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1982
• Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
• Specific binding sites in rat brain for a new and potent inhibitor of 5-hydroxytryptamine uptake: Ro 11-2465
  European Journal of Pharmacology, 1980
• Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine
  Biochemical Pharmacology, 1971
• Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine
  European Journal of Pharmacology, 1969